Back to search
FDAFDA · Food and drugs·Recall number D-1350-2014

Cefpodoxime Proxetil Tablets, USP, 200 mg, 20 Tablet Bottles, Rx Only. Manufactured in Austria by Sandoz GmbH for Sandoz Inc. Princeton, NJ 08540. NDC 0781-5439-20.

Published June 4, 2014 · Recall initiated: May 22, 2014

Summary

FDA records drug Class II recall D-1350-2014, published June 4, 2014 and initiated May 22, 2014. Recalling firm: Sandoz, Inc; Status: Terminated; Reported quantity: 22,818 Bottles; Lot: Lot #: DZ4056, Expiry: 11/2015; Lot # DZ4057, Expiry: 01/2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Substance: Presence of stainless steel particles.

What to do

Voluntary: Firm initiated · Letter

Get an email if CEFPODOXIME PROXETIL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CEFPODOXIME PROXETIL
Manufacturer
Sandoz, Inc
Distributor
Nationwide including Puerto Rico.
Lot
Lot #: DZ4056, Expiry: 11/2015; Lot # DZ4057, Expiry: 01/2016
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cefpodoxime Proxetil Tablets, USP, 200 mg, 20 Tablet Bottles, Rx Only. Manufactured in Austria by Sandoz GmbH for Sandoz Inc. Princeton, NJ 08540. NDC 0781-5439-20. recalled?

Yes. FDA published recall D-1350-2014 on June 4, 2014. Reported hazard: Presence of Foreign Substance: Presence of stainless steel particles.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CEFPODOXIME PROXETIL.